Concepedia

Publication | Open Access

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

DOIFull Paper Access

320

Citations

35

References

2011

Year

Mary Sano, Karen L. Bell, Douglas Galasko, James E. Galvin, Ronald G. Thomas, C H van Dyck, Paul Aisen
Neurology

Abstract

This study provides Class I evidence that simvastatin 40 mg/day does not slow decline on the ADAS-Cog.

References

YearCitations

Page 1